Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Transport Function and Hepatocellular Localization of mrp6 in Rat Liver
2000
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Portosystemic Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhosis: Clinical, Laboratory, Psychometric, and Electroencephalographic Investigations
1998
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
The assessment of vertebral deformity: A method for use in population studies and clinical trials
1993
Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center
2008
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study
2005
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
The treatment of chronic hepatitis C with peginterferon alfa-2a (40kDa) plus ribavirin in haemodialysed patients awaiting renal transplant
2007
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage
2006
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Hepatocellular carcinoma
2012 Standout
Primary Sclerosing Cholangitis
2005
Hepatocellular carcinoma
2021 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Efficacy of repeated high‐dose hepatitis B vaccine (80 μg) in patients with chronic liver disease
2005
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis
1999
The Oswestry Disability Index
2000 Standout
Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures
1995
Update on Nonalcoholic Fatty Liver Disease
2002
Genetics of Inflammatory Bowel Diseases
2015
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Prevalence and incidence of vertebral deformities
1993
Quality of life issues in women with vertebral fractures due to osteoporosis
1993
Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria
2008
Metabonomics: a platform for studying drug toxicity and gene function
2002 Standout
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
2008 Standout
Long-Term Morbidity and Mortality After a Clinically Diagnosed Vertebral Fracture in the Elderly—a 12- and 22-Year Follow-up of 257 Patients
2005
Primary Sclerosing Cholangitis
2016
Three-Quarters of Right Liver Donors Experienced Postoperative Complications† ‡
2007
Targeting multidrug resistance in cancer
2006 Standout
Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation
2002
Portal hypertensive bleeding in cirrhosis
2016 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Crohn's disease
2016 Standout
Non-heart beating organ donation: overview and future perspectives
2007
Wilson's disease and other neurological copper disorders
2014
Polymorphisms in the Sclerosteosis/van Buchem Disease Gene (SOST) Region Are Associated with Bone-Mineral Density in Elderly Whites
2004 StandoutNobel
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Ulcerative colitis
2016 Standout
the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009
2009
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study
2001
Immunizations in Chronic Liver Disease: What Should be Done and What is the Evidence
2012
Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value
2012
Primary sclerosing cholangitis
1999
Management of severe osteoporosis
2015
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis
2002
Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A systematic review
2011
Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
2006
Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
2014
Epidemiology of vertebral osteoporosis
1992
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
2009 Standout
Prevention of falls and consequent injuries in elderly people
2005 Standout
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
Primary sclerosing cholangitis – a comprehensive review
2017
Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer
2006
Update on primary sclerosing cholangitis
2013
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The Pathophysiology of Mitochondrial Cell Death
2004 StandoutScience
Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis
1996
Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fractures
1995
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
Gut flora and bacterial translocation in chronic liver disease
2006
Report assessing vertebral fractures
1995
Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease
2002
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Echinococcosis: Advances in the 21st Century
2019 Standout
NMR and Pattern Recognition Studies on the Time-Related Metabolic Effects of α-Naphthylisothiocyanate on Liver, Urine, and Plasma in the Rat: An Integrative Metabonomic Approach
2001
Diabetic Cardiomyopathy
2018 Standout
Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats
2003
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Bile Salt Transporters: Molecular Characterization, Function, and Regulation
2003
Response to hepatitis B vaccination in patients with liver cirrhosis
2017
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
90066279 A study of complaints and their relation to vertebral destruction in patients with osteoporosis
1990
Epidemiology of Spinal Osteoporosis
1997
Contribution of vertebral deformities to chronic back pain and disability
1992
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The diagnosis of osteoporosis
1994 Standout
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency
2015
Classification of vertebral fractures
1991
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of Peter Sauer being referenced
Comparison of a semiquantitative and a quantitative method for assessing vertebral fractures in osteoporosis
1994
Living-donor liver transplantation: evaluation of donor and recipient
2004
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates
2001
MECHANISM OF HEPATOPROTECTIVE ACTION OF BILE SALTS IN LIVER DISEASE
1999
MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation
1997
FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis
2013
Downregulation of ileal bile acid absorption in bile-duct-ligated rats
2000
Living Related Liver Transplantation: The Ultimate Technique to Expand the Donor Pool?
2005
Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer
2004
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis
1997
Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes
1998
Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment
2002
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding
1997
Endoscopic Treatment of Biliary Stenosis in Patients with Alveolar Echinococcosis – Report of 7 Consecutive Patients with Serial ERC Approach
2016
A study of complaints and their relation to vertebral destruction in patients with osteoporosis
1990
S100A9 is a Biliary Protein Marker of Disease Activity in Primary Sclerosing Cholangitis
2012
Liver Transplantation for Hepatocellular Carcinoma: Is there Evidence for Expanding the Selection Criteria?
2005
Biliary Endothelin Levels in Liver Transplant Recipients Do Not Correlate With Total Bile Acid Concentration
1998
Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis
2016
Endoscopic Variceal Ligation plus Propranolol vs. Transjugular Intrahepatic Portosystemic Stent Shunt: A Long-Term Randomized Trial
2002
Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation
2009
A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults†‡
2008
Treatment of Hepatitis C Virus Reinfection after Liver Transplantation
2005
Influence of Cholestasis on Absorption of Ursodeoxycholic Acid
1999
Fulminant hepatic failure: etiology and indications for liver transplantation
2007
Spine deformity index (SDI) versus other objective procedures of vertebral fracture identification in patients with osteoporosis: A comparative study
1991
Antibiotic prophylaxis after variceal hemorrhage reduces incidence of early rebleeding.
2004
Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis
2014
Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease
2013
Biliary secretion of bile acids and lipids in primary sclerosing cholangitis.Influence of cholestasis and effect of ursodeoxycholic acid treatment
1995
Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis
2014
A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis.
1988
Non‐IBD immunological diseases are a risk factor for reduced survival in PSC
2012